Medico Intercontinental Limited

BSE: MIL539938ISIN INE858Q01019

Services
Trading & Distributors

BSE listing

Share price

₹26.49+0.52 (+2.00%)

as of 18 Sep 2026

52W high: ₹43.00
52W low: ₹20.61
Off 52W high: -38.40%
1M return: -2.25%
3M return: +5.24%
6M return: -4.92%
1Y return: -29.55%
20D avg volume: 2,132
50 DMA: ₹26.71
200 DMA: ₹29.36

Key ratios Consolidated

Market cap: ₹26.49 Cr
Current price: ₹26.49
52W high / low: ₹43.00 / ₹20.61
Face value: ₹10.00
P/E: -2.11
P/B: —
EPS (TTM): ₹-12.54
Book value / share: —
ROE: —
ROCE: -1.50%
Operating margin: —
Net margin: —
Debt / equity: 2.08
Net debt: ₹61.17 Cr
Interest cover: -0.14
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 122.5 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	20.71	22.49	19.85	20.40	21.35	21.39	—
	0.13	0.11	0.34	0.55	0.26	0.08	—
	24.52	24.15	21.59	25.29	23.66	19.95	—
	2.79	2.35	1.31	2.42	1.61	0.00	—
	11.98	12.93	15.29	12.87	12.89	18.32	—
	2.56	2.25	2.37	2.19	1.96	1.45	—
	1.91	1.85	1.90	2.06	2.36	0.27	—
	1.21	1.43	1.43	1.95	0.62	0.28	—
	2.11	3.16	1.54	2.34	2.64	1.03	—
	-3.68	-1.55	-1.40	-4.35	-2.04	1.52	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	-3.68	-1.55	-1.40	-4.35	-2.04	1.52	—
	0.39	0.80	0.28	0.19	0.47	0.36	—
	-4.04	-2.33	-1.65	-4.51	-2.49	1.17	—
	-1.45	-0.65	-0.22	-1.65	-0.68	1.17	—
Key metrics
	-0.56	1.73	1.93	-0.34	0.94	2.07	—
	-2.70%	7.70%	9.70%	-1.70%	4.40%	9.70%	—
	-19.50%	-10.40%	-8.30%	-22.10%	-11.70%	5.50%	—
	—	0.40%	—	-2.70%	—	2.80%	—
	-3.00%	5.10%	—	—	—	—	—
	-62.20%	-299.10%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	83.45	84.08	96.02	—
	1.13	1.27	0.36	—
	95.55	94.69	89.40	—
	8.87	7.70	0.00	—
	53.07	53.97	73.41	—
	9.37	8.77	4.75	—
	7.72	8.16	1.00	—
	6.02	5.43	0.81	—
	9.15	9.69	8.24	—
	-10.98	-9.34	6.97	—
	0.00	0.00	0.00	—
	-10.98	-9.34	6.97	—
	1.66	1.75	1.92	—
	-12.53	-10.98	5.06	—
	-3.97	-3.20	5.06	—
Key metrics
	2.76	4.25	8.78	—
	3.31%	5.10%	9.10%	—
	-15.01%	-13.10%	5.30%	—
	—	-1.50%	12.70%	—
	—	-12.40%	—	—
	—	-317.00%	—	—
	—	12.44	-9.11	—
	—	-1.56	-1.41	—
	—	2.08	0.35	—
	—	61.17	14.23	—
	—	122.5	131.6	—
Balance sheet
	—	117.26	75.76	—
	—	61.25	56.58	—
	—	5.96	2.69	—
	—	27.42	32.85	—
	—	14.93	9.24	—
	—	12.94	10.78	—
	—	36.83	3.62	—
	—	14.11	7.47	—
	—	37.74	12.76	—
	—	67.13	16.92	—
	—	21.04	3.45	—
	—	46.09	13.47	—
	—	32.27	48.65	—
Cash flow
	—	17.08	-7.11	—
	—	2.20	-2.19	—
	—	-15.56	8.63	—
	—	4.64	2.00	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	14.33	15.82	12.75	12.42	13.47	15.24	—
	0.91	0.73	0.79	0.58	0.24	0.13	—
	14.43	15.82	12.70	12.19	12.97	14.68	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	11.89	13.07	12.02	10.30	9.48	13.97	—
	0.56	0.66	0.73	0.56	0.51	0.54	—
	0.48	0.40	0.39	0.45	0.44	0.23	—
	0.11	0.16	0.17	0.19	0.18	0.21	—
	0.51	1.15	0.37	0.57	1.09	0.55	—
	0.81	0.73	0.84	0.81	0.74	0.69	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.81	0.73	0.84	0.81	0.74	0.69	—
	0.21	0.31	0.23	0.21	0.18	0.16	—
	0.61	0.42	0.61	0.59	0.56	0.53	—
	0.61	0.42	0.61	0.59	0.56	0.53	—
Key metrics
	1.40	1.29	1.40	1.45	1.36	1.13	—
	9.80%	8.20%	11.00%	11.70%	10.10%	7.40%	—
	4.30%	2.70%	4.80%	4.80%	4.20%	3.50%	—
	—	2.00%	—	2.40%	—	1.80%	—
	6.40%	3.80%	—	—	—	—	—
	8.90%	-20.80%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	55.32	54.46	67.13	—
	3.01	2.35	0.51	—
	55.14	53.69	64.06	—
	0.00	0.00	0.00	—
	47.28	44.86	54.45	—
	2.51	2.46	1.74	—
	1.72	1.67	0.67	—
	0.63	0.69	0.56	—
	2.60	3.18	5.02	—
	3.19	3.12	3.58	—
	0.00	0.00	0.00	—
	3.19	3.12	3.58	—
	0.96	0.93	1.01	—
	2.23	2.18	2.57	—
	2.23	2.18	2.57	—
Key metrics
	5.54	5.48	4.81	—
	10.01%	10.10%	7.20%	—
	4.03%	4.00%	3.80%	—
	—	8.60%	8.20%	—
	—	-18.90%	—	—
	—	-15.20%	—	—
	—	15.02	-8.66	—
	—	7.08	-2.64	—
	—	0.40	0.34	—
	—	13.99	11.80	—
	—	73.6	109.4	—
Balance sheet
	—	67.42	58.77	—
	—	27.16	36.88	—
	—	2.16	1.42	—
	—	17.93	22.77	—
	—	2.11	2.94	—
	—	4.95	8.74	—
	—	1.52	1.68	—
	—	9.05	5.59	—
	—	11.46	6.95	—
	—	16.15	13.22	—
	—	1.18	0.45	—
	—	14.97	12.77	—
	—	40.85	38.66	—
Cash flow
	—	15.43	-6.78	—
	—	8.25	-4.78	—
	—	-22.94	10.57	—
	—	0.41	1.88	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Filings & corporate actions

Recent announcements

Newspaper Publication7 Sep 2026 · Company Update / Newspaper Publication
Notice of the 42nd Annual General Meeting of the Company to be held on 30th September, 2026.5 Sep 2026 · AGM/EGM / AGM
Reg. 34(1) Annual Report5 Sep 2026 · Others / Reg. 34 (1) Annual Report
Intimation of Book closure & Annual General Meeting3 Sep 2026 · Corp. Action / Book Closure
Announcement under Regulation 30 (LODR) - Newspaper Publication17 Aug 2026 · Company Update / Newspaper Publication
Results for the Quarter ended 30 June 202614 Aug 2026 · Result / Financial Results
Pursuant to provisions of Regulation 30, 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company ....14 Aug 2026 · Board Meeting / Outcome of Board Meeting
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve and take on record ....5 Aug 2026 · Board Meeting / Board Meeting
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 20189 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Windo29 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Shah & PACs25 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Submission of Disclosure25 Jun 2026 · Company Update / General
Newspaper Publication23 May 2026 · Company Update / Newspaper Publication
Intimation of Re-appointment of an Internal Auditors.22 May 2026 · Company Update / Meeting Updates
Results for the quarter and financial year ended March 31, 202622 May 2026 · Result / Financial Results
Outcome of Board meeting dated May 22, 2026.22 May 2026 · Board Meeting / Outcome of Board Meeting
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve and take on record ....14 May 2026 · Board Meeting / Board Meeting
Annual Secretarial Compliance Report under Regulation 24A of the SEBI (LODR) Regulations, 2015 for the financial year ended 31st March, 2026.16 Apr 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....8 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 20184 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window30 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication16 Feb 2026 · Company Update / Newspaper Publication
Results for the quarter and nine months ended December 31, 2025.14 Feb 2026 · Result / Financial Results
Results for the quarter and nine months ended December 31, 202514 Feb 2026 · Board Meeting / Outcome of Board Meeting
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve and take on record ....4 Feb 2026 · Board Meeting / Board Meeting
Compliances - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 20188 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window29 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Dilipkumar Shah & PACs26 Dec 2025 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Submission of Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 201526 Dec 2025 · Company Update / General
Announcement under Regulation 30 (LODR) - Newspaper Publication15 Nov 2025 · Company Update / Newspaper Publication
Results - Financial results for the quarter and half year ended September 30, 202514 Nov 2025 · Result / Financial Results
Outcome of Board meeting held on November 14, 202514 Nov 2025 · Board Meeting / Outcome of Board Meeting
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Board Meeting Intimation ....6 Nov 2025 · Board Meeting / Board Meeting
Compliances - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 20189 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Announcement under Regulation 30 (LODR) - Annual General Meeting updates1 Oct 2025 · Company Update / Meeting Updates
VOTING RESULTS ALONG WITH SCRUTINIZER REPORT1 Oct 2025 · AGM/EGM / AGM
Proceedings of the 41st Annual General Meeting of the Company held on September 30, 2025.30 Sep 2025 · AGM/EGM / AGM
Closure of Trading Window29 Sep 2025 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication8 Sep 2025 · Company Update / Newspaper Publication
Annual Report for the FY 2024-256 Sep 2025 · Others / Reg. 34 (1) Annual Report

Board meetings

14 Aug 2026 Board Meeting - Financial Results